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Abstract
Phosphoglycerate kinase 1 (PGK1) catalyzes the reversible transfer of a phosphoryl group
from 1, 3-bisphosphoglycerate (1, 3-BPG) to ADP, producing 3-phosphoglycerate (3-PG)
and ATP. PGK1 plays a key role in coordinating glycolytic energy production with one-car-
bon metabolism, serine biosynthesis, and cellular redox regulation. Here, we report that
PGK1 is acetylated at lysine 220 (K220), which inhibits PGK1 activity by disrupting the bind-
ing with its substrate, ADP. We have identified KAT9 and HDAC3 as the potential acetyl-
transferase and deacetylase, respectively, for PGK1. Insulin promotes K220 deacetylation
to stimulate PGK1 activity. We show that the PI3K/AKT/mTOR pathway regulates HDAC3
S424 phosphorylation, which promotes HDAC3-PGK1 interaction and PGK1 K220 deacety-
lation. Our study uncovers a previously unknown mechanism for the insulin and mTOR
pathway in regulation of glycolytic ATP production and cellular redox potential via HDAC3-
mediated PGK1 deacetylation.
Author Summary
Phosphoglycerate kinase (PGK1) catalyzes the reversible phosphotransfer reaction from 1,
3-bisphosphoglycerate (1, 3-BPG) to ADP to form 3-phosphoglycerate (3-PG) and ATP.
By controlling ATP and 3-PG levels, PGK1 plays an important role in coordinating energy
production with biosynthesis and redox balance. In contrast to the extensive investigation
of the transcriptional regulation of PGK1, little is known about its post-translational regu-
lation. Here, we report that PGK1 is acetylated at lysine 220 (K220) and this acetylation
inhibits PGK1 activity by disrupting the binding with its substrate, ADP. We have
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identified KAT9 and HDAC3 as the acetyltransferase and deacetylase, respectively, for
PGK1. Moreover, we show there is molecular crosstalk between mTOR-mediated HDAC3
S424 phosphorylation and PGK1 K220 acetylation. Our study uncovers a previously
unknown mechanism for the insulin and mTOR pathway in regulating glycolytic ATP
production and cellular redox potential via HDAC3-mediated PGK1 deacetylation.
Introduction
Phosphoglycerate kinase (EC 2.7.2.3; PGK) catalyzes the reversible phosphotransfer reaction
from 1, 3-bisphosphoglycerate (1, 3-BPG) to ADP to form 3-phosphoglycerate (3-PG) and
ATP. The PGK-catalyzed reaction is the first ATP-yielding step of glycolysis and is essential
for energy generation by the glycolytic pathway of aerobes and the fermentation of anaerobes
in most living cells [1]. Besides ATP, the other product of PGK-catalyzed reaction is 3-PG,
which can not only serve as a glycolytic intermediate but also be oxidized by phosphoglycerate
dehydrogenase (PHGDH) to form 3-phosphohydroxypyruvate and thus enter one-carbon
metabolism [2]. It is known that one-carbon metabolism involving the folate and methionine
cycle integrates carbon units from amino acids, including serine and glycine, and creates vari-
ous outputs, such as the maintenance of redox status by affecting glutathione biosynthesis and
NADPH production, the synthesis of lipids, nucleotides, and substrate for methylation reac-
tions [3–5]. By controlling ATP and 3-PG levels, PGK therefore plays an important role in
coordinating energy production with biosynthesis and redox balance.
Regulation of PGK has been studied extensively, with research mostly focused on the tran-
scriptional level. In yeast cells, PGK is one of the most highly expressed genes and accounts for
approximately 5% of the total mRNA and protein [6]. PGK gene expression can be regulated by
diverse carbon sources, with glucose induction and pyruvate suppression having been observed
in yeast cells [7–9]. PGK gene expression is also up-regulated by oxidative stress [10]. Overex-
pression of PGK can suppress the apoptotic phenotypes induced by high ROS and restore normal
aging of yeast cells [11]. In humans, PGK has two isoforms (PGK1 and PGK2), which share 87%
identity in amino acid sequence and are structurally and functionally similar, but have different
expression patterns [12–14]. PGK1 (Gene ID: 5230) is broadly expressed in most cell types, while
PGK2 (Gene ID: 5232) is uniquely expressed in meiotic and postmeiotic spermatogenic cells
[13]. PGK1 gene as the target of the hypoxia-inducible transcriptional factor HIF-1α has been
reported to be selectively up-regulated by oxidants in cultured human colon carcinoma cells [15]
and hepatoblastoma cells [16,17]. In contrast to the extensive investigation on the transcriptional
regulation of PGK1, little is known about its post-translational regulation.
Protein acetylation has recently been discovered as an evolutionarily conserved post-trans-
lational modification in the regulation of a wide range of cellular processes, particularly in
nuclear transcription and cytoplasmic metabolism [18–20]. Together with several recent acety-
lome proteomic studies [21–23], more than 4,500 acetylated proteins, including human PGK1,
have been identified by the mass spectrometric analyses. In this study, we investigate the regu-
latory mechanism and functional consequence of PGK1 acetylation.
Results
K220 Acetylation Inhibits PGK1 Activity via Blocking Its Binding with
Substrate ADP
Previous proteomic studies have identified that PGK1 is acetylated on multiple lysine residues
[18–20]. Western blotting with a pan anti-acetyl lysine antibody demonstrated that PGK1 was
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indeed acetylated, and its acetylation was elevated by 3.2-fold in HEK293T cells after treatment
with nicotinamide (NAM), an inhibitor of the SIRT family deacetylases [24,25], and trichosta-
tin A (TSA), an inhibitor of histone deacetylase (HDAC) I and II (Fig 1A) [26,27]. By perform-
ing enzyme activity assay in vitro, we found that the specific enzyme activity of PGK1 was
decreased by as much as 63% after NAM and TSA treatment (Fig 1A), suggesting that acetyla-
tion negatively regulates PGK1 activity. Notably, the effect of TSA on increasing PGK1 acetyla-
tion and decreasing PGK1 activity was more potent than that of NAM (Figs 1A, S1A and S1B),
implying that a HDAC I and/or II is the major deacetylase for PGK1.
Given that PGK1 is a highly conserved protein [28], we speculated that important regula-
tory sites in PGK1 targeted by acetylation might also be conserved. Sequence alignments from
diverse species revealed that of twenty putative acetylated lysines identified by the different
mass spectrometric analyses, fifteen lysine residues (K11, K30, K48, K86, K91, K97, K131,
K146, K156, K192, K199, K264, K267, K291, K323) are not conserved, while five (K75, K139,
K141, K220, K406) are invariably conserved (S2 Fig). To determine which lysine residue(s)
plays a major role in the regulation of PGK1, we mutated each of the five conserved putative
acetylated lysine residues in PGK1 to arginine (R) or glutamine (Q) and assayed their enzyme
activity individually. The K to R mutation is often used as a deacetylation mimetic, whereas the
K to Q mutation may act as a surrogate of acetylation [29]. We found that substitution at
K220, but not the other four lysine residues (K75, K139, K141, and K406), by arginine substan-
tially reduced PGK1 enzyme activity by 82% (Fig 1B), indicating K220 has an important role in
controlling PGK1 activity. Moreover, both the K220R and K220Q mutants exhibited a negligi-
ble response in changing acetylation level and enzyme activity upon NAM and TSA treatment
(Figs 1C and S3), re-affirming that K220 is a major acetylation site in PGK1.
PGK1 exists as a monomer comprising two nearly equal-sized N- and C-terminal domains.
This extended two-domain structure is associated with large-scale “hinge-bending” conforma-
tional changes, bringing the two substrates into close proximity, with 3-PG or 1,3-BPG binding
to the N-terminal domain and the nucleotide substrate ADP binding to the C-terminal domain
of the enzyme [30,31]. PGK1 in complex with 3-PG, ADP, and tetrafluoroaluminate (ALF)
results in a fully active and closed conformation [14]. Molecular modeling predicts that K220
acetylation disturbs PGK1’s binding with ADP (Fig 1D), suggesting that K220 acetylation may
inhibit PGK1 enzyme activity by blocking the substrate ADP binding.
To test this hypothesis, we employed an expression system genetically encoding Nε-acetylly-
sine to prepare recombinant PGK1 protein that was completely acetylated on K220 in Escheri-
chia coli [32,33]. Briefly, the K220 codon in PGK1 was mutated to an amber stop codon. An
amber suppressor tRNA and a tRNA synthetase that could conjugate the acetyllysine to the
amber tRNA suppressor were also expressed in the bacteria. Therefore, in the presence of acet-
yllysine added in the culture medium, the amber stop codon at the position of K220 was
replaced by an acetyllysine when PGK1 was expressed in the genetically engineered E. coli
strain. This expression system produced PGK1 proteins with 100% acetylation at the lysine res-
idue 220. Moreover, we generated and verified an antibody that specifically recognizes the
K220 acetylated PGK1 [α-acPGK1(K220)] (S4A, S4B and S4C Fig). The K220 acetylation of
the recombinant PGK1 was confirmed by immunoblotting with the site-specific α-acPGK1
(K220) antibody (Fig 1E). Consistent with the structural prediction, the recombinant
PGK1K220ac protein was catalytically inactive when compared to recombinant wild-type PGK1.
Importantly, isothermal titration calorimetry (ITC) analysis demonstrated that the recombi-
nant PGK1K220ac protein was defective in binding with ADP (Fig 1F). These results provide
direct and unequivocal biochemical evidence to support a model that K220 acetylation in
PGK1 inhibits its enzymatic activity by blocking the substrate ADP binding.
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Fig 1. Acetylation of PGK1 K220 blocks substrate ADP binding and inhibits PGK1 activity. (A)
Acetylation inhibits PGK1 enzyme activity. Flag-PGK1 was overexpressed in HEK293T cells followed by
treatment with nicotinamide (NAM, 10 mM for 4 hr), trichostatin (TSA, 5 μM for 12 hr), or NAM and TSA (N+T).
Acetylation levels and enzyme activity of Flag-bead-purified PGK1 were determined by western blot analysis
and enzyme assay, respectively. Acetylation levels were blotted with a pan-anti-acetyllysine antibody (α-Ac).
The catalytic activity of affinity purified PGK1 was determined and normalized to protein levels. PGK1 activity
under no treatment condition was set as 1. PGK1 acetylation levels were normalized against Flag IB as
indicated on the top of each lane. IB and IP denote immunoblotting and immunoprecipitation, respectively.
(B) Mapping the major regulatory acetylation sites in PGK1. Wild-type (WT) PGK1 and the indicated mutants
were each expressed in HEK293T cells. Proteins were purified by IP, and PGK1 activity was determined.
Relative PGK1 acetylation levels were normalized against Flag. (C) K220 is a major regulatory acetylation
site in PGK1. Flag-tagged wild-type and K220 mutant PGK1 were each expressed in HEK293T cells,
following treatments with or without NAM (10 mM, 4 hr) and TSA (5 μM, 12 hr). Acetylation levels and enzyme
HDAC3 Deacetylates PGK1
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KAT9/ELP3 Is a Potential Acetyltransferase of PGK1
The acetylation state of a given protein is controlled by the action of lysine acetyltransferases
(KATs) and deacetylases (KDACs), enzymes that catalyze the addition and removal, respec-
tively, of an acetyl group from a lysine residue. To search for potential KAT(s) which are
responsible for PGK1 K220 acetylation, we generated a siRNA library with three siRNAs tar-
geting each of the 19 human KAT genes [34]. The knockdown efficiency of each siRNA against
corresponding KAT genes was determined by quantitative RT-PCR (S5 Fig and S1 Table). We
found that knockdown of ATF2 (Gene ID: 1386), KAT5 (Gene ID: 10524), KAT6A (Gene ID:
7994), KAT9 (Gene ID: 55140), KAT12 (Gene ID: 9329), or KAT13B (Gene ID: 8202) led to an
increase in cellular PGK1 enzyme activity (Fig 2A), indicating that these KAT enzymes may
play a direct or indirect role in the regulation of PGK1 activity. Among these six candidate
KAT genes, knockdown of KAT9 (also known as ELP3), but not the other five KATs, signifi-
cantly decreased the K220 acetylation level of endogenous PGK1 without changing its protein
expression in HEK293T cells (Fig 2B and 2C). In a converse experiment, co-overexpression of
HA-KAT9 with Flag-PGK1 increased the PGK1 K220 acetylation level by 2.2-fold and
decreased PGK1 activity by 36% (Fig 2D). Collectively, these results indicate that KAT9 is a
potential acetyltransferase of PGK1.
HDAC3 Deacetylates and Activates PGK1
Our earlier observation that TSA is more potent than NAM to increase PGK1 acetylation and
inhibit PGK1 activity (Fig 1A) led us to search for the HDAC enzyme(s) that mediates PGK1
deacetylation. We found by binding assay that PGK1 interacted with HDAC3 (NP_003874.2),
but not the other six HDACs, when co-expressed in HEK293T cells (Fig 3A). The endogenous
protein interaction between HDAC3 and PGK1 was readily detected in HEK293T cells (Fig
3B). Furthermore, based on the protein amount and the immunoprecipitation efficiency, we
found that ~16% of endogenous HDAC3 interacted with endogenous PGK1 (Fig 3B). Co-over-
expression of HA-HDAC3 with Flag-PGK1 decreased the acetylation level of PGK1 by 75%,
and increased PGK1 activity by ~1.6-fold (Fig 3C). In contrast, co-overexpression of HA-H-
DAC3 with the K220R/Q mutants of PGK1 did not change PGK1 acetylation or enzyme activ-
ity (Fig 3C). When PGK1 was co-overexpressed with a catalytic inactive mutant HDAC3Y298H
[35], neither PGK1 acetylation nor enzyme activity was altered (Fig 3D). Conversely, depletion
ofHDAC3 increased the K220 acetylation level of endogenous PGK1 by>2-fold and decreased
PGK1 activity by>50% in HEK293T cells (Fig 3E). More importantly, we performed in vitro
pull-down assay using purified recombinant proteins of His-PGK1 and GST-HDAC3, and
found that HDAC3 directly binds with PGK1 in vitro (Fig 3F). Furthermore, in vitro
activity of PGK1 were determined. (D) Molecular interaction between PGK1 and its substrates. As shown,
PGK1 is rendered in cyan-colored illustrations, and ADP is in sticks and colored by atom type with magenta
illustrations. The left panel shows that PGK1 in complex with ADP, 3-PG, and ALF (tertrafluoroaluminate)
results in an active and fully closed conformation. A gray dashed line represents the hydrogen bond between
K220 and ADP. 3-PG and ALF are also rendered in sticks, and colored by atom type, with carbons colored
magenta. The right panel shows that the interaction between an acetylated K220 (white carbons) and ADP is
disrupted. (E) Purification of K220 acetylated PGK1. His-tagged PGK1 and PGK1K220ac were recombinantly
expressed and purified from a genetically engineered Escherichia coli. PGK1 protein and K220 acetylation
were detected with anti-His antibody as well as a site-specific anti-acetyllysine antibody [α-acPGK1(K220)].
(F) PGK1 K220 acetylation blocks ADP binding. The purified unacetylated PGK1 and PGK1K220ac proteins
were measured for their binding with substrate ADP as determined by isothermal calorimetric titration (ITC).
Shown are average values with standard deviation (S.D.) of triplicated experiments. ** denotes that p < 0.01
for the indicated comparison; n.s. = not significant. The numerical data and statistical analysis used in the
figures are included in S1 Data. Supporting information can be found in S1, S2, S3 and S4 Figs.
doi:10.1371/journal.pbio.1002243.g001
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Fig 2. KAT9 acetylates PGK1 and inhibits PGK1 activity. (A) Knockdown of ATF2, KAT5, KAT6A, KAT9,
KAT12, or KAT13B leads to increased enzyme activity of endogenous PGK1. HEK293T cells were transiently
transfected with the indicated siRNAs. The enzyme activity of endogenous PGK1 was determined as
described in “Methods and Materials.” (B, C) KAT9 knockdown leads to decreased K220 acetylation of
endogenous PGK1. HEK293T cells were transiently transfected with the indicated siRNAs. The protein levels
and K220 acetylation of endogenous PGK1 were determined by western blot (B). Moreover, HEK293T cells
were transiently transfected with three different siRNAs targeting KAT9, and the K220 acetylation level of
endogenous PGK1 was determined by western blot (C). “Scr” means scramble. Relative PGK1 K220
acetylation levels were normalized against endogenous PGK1. (D) KAT9 overexpression increases PGK1
K220 acetylation and inhibits PGK1 enzyme activity. Flag-tagged PGK1 and HA-tagged KAT9 were
transiently co-overexpressed in HEK293T cells, and PGK1 protein was purified by IP with Flag beads, the
K220 acetylation level and enzyme activity of PGK1 were determined by western blot and enzyme assay,
respectively. Relative PGK1 acetylation levels were normalized against Flag. Shown are average values with
standard deviation (S.D.) of triplicated experiments. ** denotes the p < 0.01 for the indicated comparison; n.
s. = not significant. The numerical data and statistical analysis used in the figures are included in S1 Data.
Supporting information can be found in S5 Fig and S1 Table.
doi:10.1371/journal.pbio.1002243.g002
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Fig 3. HDAC3 deacetylates and activates PGK1. (A, B) PGK1 interacts with HDAC3. Flag-tagged PGK1
was overexpressed in HEK293T cells together with the individual HA-tagged HDAC as indicated. PGK1
protein was purified by IP with Flag beads, following western blot to detect HDACs with a human influenza
hemagglutinin (HA) antibody (A). In addition, PGK1 protein was purified by IP with PGK1 antibody, following
western blot to detect its interacting endogenous HDAC3 (B). ‘5.7% input’ refers to 5.7% of total proteins for
IP experiments were loaded. Based on the protein amount as determined by western blotting and
chemiluminescent detection, the protein level of immunorecipitated PGK1 is 3.9 times of PGK1 input, and the
protein level of co-immunorecipitated HDAC3 is 0.64 times of HDAC3 input. Thus, the IP efficiency for PGK1
is 3.9 × 5.7% = 22.2%, and the co-IP efficiency for HDAC3 is 0.64 × 5.7% = 3.6%. This indicates that ~16%
(3.6%/22.2% = 16%) of endogenous HDAC3 interacting with PGK1. (C) HDAC3 deacetylates PGK1 mainly
at the site of K220. Flag-tagged wild-type and K220 mutant PGK1 were each expressed in HEK293T cells co-
HDAC3 Deacetylates PGK1
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deacetylation assay using Flag-tagged PGK1 and GST-HDAC3 confirmed that PGK1 is a direct
substrate of HDAC3 and that HDAC3-mediated K220 deacetylation increases PGK1 activity
(Fig 3G).
Insulin Promotes K220 Deacetylation to Stimulate PGK1 Activity
Previous studies have shown that PGK1 gene expression is regulated by nutrient availability in
yeast [7–9], indicating that PGK1may respond to energy status to maintain cellular energy homeo-
stasis. We found that PGK1 activity was dose-dependently stimulated by insulin, an important
metabolism and energy regulator, and this activation was associated with a concomitant reduction
of PGK1 K220 acetylation (Fig 4A). The effect of insulin on PGK1 K220 acetylation and activity
was suppressed by TSA treatment (Fig 4A). Moreover, the K220Rmutant PGK1 displayed a negli-
gible change in K220 acetylation and enzyme activity upon insulin stimulation (Fig 4B), indicating
that K220 is a vital site for PGK1 deacetylation and enzymatic activation by insulin.
Next, we determined the K220 acetylation level of endogenous PGK1 in HEK293T cells. By
using the recombinant PGK1K220ac protein purified from E. coli as the standard, we found that
~37% of endogenous PGK1 was acetylated at K220, and that insulin treatment decreased
PGK1 acetylation to 11% (Fig 4C). The fact that a significant fraction of endogenous PGK1
undergoes deacetylation upon insulin treatment suggests that K220 acetylation plays a physio-
logically relevant role in PGK1 regulation.
Furthermore, we assessed PGK1 K220 acetylation in mouse tissues after insulin injection.
As expected, intraperitoneal injection of insulin (5 U/kg) resulted in a transient drop in blood
glucose levels (Fig 4D). Interestingly, the K220 acetylation level of endogenous Pgk1 in mouse
livers was significantly (p< 0.01) decreased and bottomed at 60 min after insulin injection, fol-
lowed by a period of recovery in parallel with the blood glucose levels (Fig 4D and 4E). Simi-
larly, Pgk1 K220 acetylation was dynamically changed in mouse kidneys after insulin injection
(S6 Fig). Together, these findings suggest that K220 acetylation plays a signaling role in regulat-
ing PGK1 function both in cultured cells and in mouse tissues upon insulin treatment.
Insulin Decreases K220 Acetylation by Enhancing PGK1-HDAC3
Association
We next set out to investigate how insulin signal regulates PGK1 K220 acetylation and activity.
We found that insulin signal did not change KAT9 gene expression in HEK293T cells (S7A Fig).
expressing HA-tagged HDAC3. PGK1 proteins were purified by Flag beads, and acetylation and enzyme
activity were determined by western blot and enzyme assay, respectively. Relative PGK1 acetylation levels
were normalized against Flag. (D) PGK1 deacetylation and activation are directly associated with HDAC3
catalytic activity. Flag-tagged wild-type and K220Rmutant PGK1 were each expressed in HEK293T cells co-
expressing HA-tagged HDAC3 or its catalytic inactive mutant HDAC3Y298H. PGK1 proteins were purified by
Flag beads, and acetylation and enzyme activity were determined by western blot and enzyme assay,
respectively. Relative PGK1 acetylation levels were normalized against Flag. (E) HDAC3 knockdown inhibits
PGK1 activity via increasing PGK1 K220 acetylation. TheHDAC3 knockdown efficiency was verified by
western blot using an antibody against HDAC3. The K220 acetylation level and enzyme activity of PGK1
were determined by western blot analysis and enzyme assay, respectively. ‘Scr’ means scramble. Relative
PGK1 K220 acetylation levels were normalized against endogenous PGK1. (F) HDAC3 directly binds with
PGK1. Recombinant proteins of GST-HDAC3 (30 μg) and His-PGK1 (10 μg) were purified from E. coli. In
vitro pull-down assay was performed as described in S1 Text. (G) HDAC3 directly deacetylates PGK1. Flag-
tagged PGK1 proteins were overexpressed in HEK293T cells and then purified by IP with Flag beads,
following incubation with recombinant protein of GST-HDAC3 (30 μg) without or with TSA (5 μM). The K220
acetylation level and enzyme activity of PGK1 were determined by western blot and enzyme assay,
respectively. Relative PGK1 acetylation levels were normalized against Flag. Shown are average values with
standard deviation (S.D.) of triplicated experiments. ** denotes the p < 0.01 for the indicated comparison; n.
s. = not significant. The numerical data and statistical analysis used in the figures are included in S1 Data.
doi:10.1371/journal.pbio.1002243.g003
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Fig 4. Insulin promotes K220 acetylation to stimulate PGK1 activity. (A) TSA treatment blocks the effect
of insulin on changing PGK1 K220 acetylation and enzyme activity. Flag-tagged PGK1 was ectopically
expressed in HEK293T cells treated with increased concentrations of insulin as indicated, and these cells
were co-treated with or without TSA (5 μM for 12 hr). PGK1 proteins were purified by Flag beads. The K220
acetylation levels and enzyme activity were determined by western blot analysis and enzyme assay,
respectively. Relative K220 acetylation levels were normalized against Flag. (B) K220Rmutant PGK1
displays a negligible response in changing K220 acetylation and enzyme activity upon insulin treatment.
Flag-tagged wild-type or K220Rmutant PGK1 were transiently overexpressed in HEK293T cells treated with
increased concentrations of insulin as indicated. PGK1 proteins were purified by Flag beads. The K220
acetylation levels and enzyme activity were determined by western blot analysis and enzyme assay,
respectively. Relative K220 acetylation levels were normalized against Flag. (C) Quantification of the
percentage of K220 acetylated endogenous PGK1 in HEK293T cells. Recombinant fully K220 acetylated
PGK1 was loaded onto the same gel, together with endogenous PGK1 from HEK293T cells treated without or
with insulin (25 nM, 2 hr). PGK1 protein and K220 acetylation were detected by western blot. Relative PGK1
K220 acetylation levels were normalized against endogenous PGK1. (D, E) Quantification of the percentage
of K220 acetylated endogenous Pgk1 in mouse livers. Insulin (5 U/kg) was intraperitoneally injected into wild-
type mice, and blood glucose levels were measured at the indicated time points after injection. Mouse livers
were harvested at the indicated time points post injection, and the K220 acetylation levels of endogenous
Pgk1 were determined by western blot. Relative Pgk1 K220 acetylation levels were normalized against
endogenous Pgk1. Shown are average values with standard deviation (S.D.) of triplicated experiments. *
denotes p < 0.05 and ** denotes p < 0.01 versus t = 0 (before injection); n.s. = not significant. The numerical
data and statistical analysis used in the figures are included in S1 Data. Supporting information can be found
in S6 Fig.
doi:10.1371/journal.pbio.1002243.g004
HDAC3 Deacetylates PGK1
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The PGK1-KAT9 protein association was readily detected in cells co-overexpressing Flag-PGK1
and HA-KAT9, leading to an increase in PGK1 K220 acetylation (S7B Fig). However, neither the
KAT9-PGK1 protein interaction nor PGK1 K220 acetylation was affected by insulin treatment in
cells co-overexpressing PGK1 and KAT9 (S7B Fig). These findings suggest that KAT9 may not
contribute to insulin-regulated PGK1 acetylation.
On the other hand, we observed that the effect of insulin on reducing the K220 acetylation
level of endogenous PGK1 was diminished in HEK293T cells whenHDAC3 was depleted by
siRNA (Fig 5A). Insulin treatment did not change HDAC3 gene expression in HEK293T cells
(S8 Fig), but could enhance endogenous PGK1-HDAC3 association and decrease PGK1 K220
acetylation in a dose-dependent manner (Fig 5B). In agreement, insulin injection reduced Pgk1
K220 acetylation and increased Pgk1-Hdac3 interaction in mouse livers (Fig 5C). Together,
these results suggest that insulin promotes PGK1 K220 deacetylation likely through enhancing
PGK1-HDAC3 association.
S424 Phosphorylation of HDAC3 Promotes Its Binding with PGK1
Recent studies have identified HDAC3 as a phosphorylated protein, with Ser424 being one of
the key phosphorylation sites [36,37]. Protein kinase CK2 has been reported to be responsible
for HDAC3 S424 phosphorylation [38]. Mutation of serine (S) 424 to alanine (A) (mimics
dephosphorylation) inhibits HDAC3 enzyme activity without affecting its expression or sub-
cellular localization [38]. In accord, we found that the HDAC3S424A mutant displayed a ~50%
reduction in enzyme activity (S9 Fig). Strikingly, we observed that HDAC3S424A mutant exhib-
ited impaired association with endogenous PGK1 in HEK293T cells (S9 Fig), suggesting that
Ser424 phosphorylation is critical for not only the deacetylase activity of HDAC3 but also its
interaction with PGK1. To provide further evidence to support this notion, we transfected
HEK293T cells singularly with plasmid expressing Flag-PGK1 or with plasmids co-expressing
Flag-PGK1 and HA-HDAC3. Lysates from transfected cells were first immunoprecipitated
with Flag antibody and then the remaining supernatant was precipitated with HA antibody.
We found that HA-HDAC3 was co-precipitated with Flag-PGK1 (Fig 5D). Importantly,
HA-HDAC3 in the PGK1 immune complex was highly phosphorylated on Ser424, whereas
the free HDAC3 was weakly phosphorylated. These results suggest that Ser424 phosphoryla-
tion of HDAC3 may enhance its interaction with PGK1.
The mTOR Pathway Regulates HDAC3 S424 Phosphorylation and
PGK1 K220 Acetylation
Previous studies have shown that HDAC3 phosphorylation is regulated by phosphoinositide-
3-kinase/AKT (PI3K/AKT) pathway [39]. In addition, HDAC3 has also been identified as a
downstream target of mTOR [36,37]. This led us to hypothesize that the PI3K/AKT/mTOR
signaling pathway may regulate HDAC3 S424 phosphorylation and PGK1 K220 acetylation in
response to insulin. To test this hypothesis, we treated HEK293T cells co-overexpressing Flag-
PGK1 and HA-HDAC3 with either LY294002 or Wortmannin, two specific PI3K inhibitors.
As expected, either PI3K inhibitor profoundly attenuated AKT S473 phosphorylation (S10A
and S10B Fig). Notably, both LY294002 and Wortmannin dose-dependently increased K220
acetylation of ectopically expressed Flag-PGK1 and decreased the interaction between ectopi-
cally expressed PGK1 and HDAC3 (S10A and S10B Fig). In accord, both LY294002 andWort-
mannin dose-dependently increased K220 acetylation of endogenous PGK1 and decreased
endogenous PGK1-HDAC3 association in HEK293T cells (Fig 6A and 6B). In addition, MK-
2206 2HCI, a specific AKT inhibitor, produced similar effects on changing PGK1 K220 acetyla-
tion and PGK1-HDAC3 association as the PI3K inhibitor LY294002 or Wortmannin (Fig 6C).
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Furthermore, we observed that the mTOR inhibitor Rapamycin profoundly attenuated S6K
T389 phosphorylation as expected, reduced HDAC3 Ser424 phosphorylation, impaired endog-
enous PGK1-HDAC3 interaction, and increased PGK1 K220 acetylation (Fig 6D). Collectively,
these findings demonstrate that the PI3K/AKT/mTOR pathway can regulate PGK1 K220
Fig 5. S424 Phosphorylation of HDAC3 promotes its binding with PGK1. (A) HDAC3 knockdown
prevents the effect of insulin on changing PGK1 K220 acetylation and enzyme activity. HEK293T cells were
transiently transfected with siRNAs againstHDAC3. At 48 hr post transfection, cells were treated with 50 nM
insulin for 2 hr. “Scr” denotes scramble siRNA control. The K220 acetylation level of endogenous PGK1 was
determined by western blot, and then normalized against endogenous PGK1. (B) Insulin enhances PGK1
interaction with HDAC3. HEK293T cells were treated with insulin at the indicated concentrations for 2 hr.
PGK1 protein was immunoprecipitated and followed by western blot to detect the K220 acetylation and
interaction with HDAC3. The phrase “9.5% input” refers to the fact that 9.5% of total proteins for IP
experiments were loaded. (C) Insulin increases Pgk1 K220 acetylation and interaction with Hdac3 in mouse
livers. Insulin (5 U/kg) was intraperitoneally injected into wild-type mice. At the indicated time points post
injection, mouse livers were harvested, and the Pgk1 K220 acetylation and interaction with Hdac3 were
determined by western-blot. The phrase “5.7% input” refers to the fact that 5.7% of total proteins for IP
experiments were loaded. (D) Ser424 phosphorylated HDAC3 preferentially interacts with PGK1. HA-HDAC3
was transiently transfected with or without Flag-PGK1 into HEK293T cells. Cell lysates were
immunoprecipitated with Flag antibody as indicated by first IP Ppt. The remaining supernatant (Sup) was
precipitated with HA antibody (second IP). An equal amount of HA-HDAC3 from the first Flag-PGK1 co-IP or
the second HA-HDAC3 IP was used to detect Ser424 phosphorylation with the phosphoSer424 antibody (as
indicated by P-HDAC3(S424)). Supporting information can be found in S7, S8 and S9 Figs.
doi:10.1371/journal.pbio.1002243.g005
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Fig 6. ThemTOR pathway regulates HDAC3 S424 phosphorylation and PGK1 K220 acetylation. (A, B)
Inhibition of PI3K increases the K220 acetylation level of endogenous PGK1. HEK293T cells were treated
with two PI3K inhibitors, LY294002 (A) andWortmannin (B), at the indicated concentrations for 4 hr and 2 hr,
respectively. PGK1 protein was purified by IP with PGK1 antibody, following western blot to detect the K220
acetylation level of endogenous PGK1 and its interacting endogenous HDAC3. (C) Inhibition of AKT
increases the K220 acetylation level of endogenous PGK1. HEK293T cells were treated with MK-2206 2HCI
(a specific AKT inhibitor) at the indicated concentrations for 2 hr. PGK1 protein was purified by IP with PGK1
antibody, following western blot to detect the K220 acetylation level of endogenous PGK1 and its interacting
endogenous HDAC3. AKT protein and AKT S473 phosphorylation levels were detected with anti-AKT
antibody as well as anti-pAKT(S473) antibody. (D) Inhibition of mTOR decreases HDAC3 Ser424
phosphorylation and increases PGK1 K220 acetylation. HEK293T cells were treated with Rapamycin for 2 hr.
Endogenous HDAC3 and PGK1 were immunopurified with HDAC3 and PGK1 antibodies, respectively,
followed by western blotting to detect HDAC3 Ser424 phosphorylation and PGK1 K220 acetylation. S6K
protein and S6K T389 phosphorylation levels were detected with anti-S6K antibody as well as anti-pS6K
(T389) antibody. The phrase “9.5% input” refers to the fact that 9.5% of total proteins for IP experiments were
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acetylation, possibly through controlling HDAC3 S424 phosphorylation and HDAC3–PGK1
protein interaction.
The PI3K/AKT/mTOR pathway is regulated by a wide variety of cellular signals, including
insulin [40]. We then studied the role of the PI3K/AKT/mTOR pathway in mediating insulin
signal to control PGK1 K220 acetylation. As shown, insulin increased HDAC3 Ser424 phos-
phorylation and enhanced the interaction between ectopically expressed proteins of HDAC3
and PGK1 (Fig 6E). The dephosphorylation-mimicking HDAC3S424A mutant exhibited weak
binding to PGK1 even upon insulin treatment (Fig 6E), supporting the notion that HDAC3
S424 is a key site for regulating HDAC3-PGK1 association upon insulin stimulation. Rapamy-
cin treatment decreased HDAC3 Ser424 phosphorylation, impaired protein interaction
between endogenous HDAC3 and PGK1, and increased PGK1 K220 acetylation (Fig 6F).
Moreover, rapamycin abolished the effect of insulin on changing HDAC3 Ser424 phosphoryla-
tion, HDAC3-PGK1 association, and PGK1 K220 acetylation (Fig 6F). Besides insulin, other
growth factors, such as EGF, may also enhance the PI3K/mTOR pathway [41]. We found that
EGF stimulation increased ERK1/2 phosphorylation, but not S6K T389 phosphorylation, in
HEK293T cells, suggesting that EGF cannot potently activate mTOR in our experiment. As a
result, EGF treatment did not change HDAC3 S424 phosphorylation and PGK1 K220 acetyla-
tion (S11 Fig). Collectively, these data suggest that the mTOR pathway regulates PGK1 K220
acetylation through controlling HDAC3 S424 phosphorylation.
PGK1 K220 Acetylation Regulates Glycolytic ATP Production, Glucose
Metabolism, and Redox Status
To address the physiological significance of PGK1 regulation by K220 acetylation, we gener-
ated stable HEK293T cells in which endogenous PGK1 was depleted, and wild-type or K220
mutant PGK1 was re-introduced at a comparable level (knockdown and put-back, S12 Fig).
We found that ATP production did not differ between wild-type and PGK1K220Q mutant put-
back cells (Fig 7A). We then treated these stable cells with rotenone, a chemical which inhibits
the complex I of the respiratory chain and thus mitochondrial ATP production [42,43]. A
short-term treatment with rotenone greatly decreased cellular ATP production without induc-
ing substantial cell death (S13 Fig). Notably, PGK1K220Q mutant put-back cells displayed a
remarkable reduction (by 76%; p< 0.01) in glycolytic ATP production compared to wild-type
rescued cells (Fig 7A). Liquid chromatography-mass spectrometry (LC-MS) analysis demon-
strated that the level of 3-PG, which is the product of PGK1 catalysis, was dramatically reduced,
by 89% (p< 0.05), in PGK1K220Q mutant put-back cells compared to wild-type rescued cells
(Fig 7B). 3-PG can be oxidized to 3-phosphohydroxypyruvate for de novo (that is originated
from glucose) serine biosynthesis [44]. In accord with reduced 3-PG, the serine level was signif-
icantly decreased (by 64%; p< 0.01) in PGK1K220Q mutant put-back cells (Fig 7B). Moreover,
extracellular acidification rate (ECAR) analysis revealed that several parameters reflecting the
loaded. (E) HDAC3 Ser424 is required for insulin to promote HDAC3-PGK1 interaction. Flag-PGK1 was co-
overexpressed with HA-tagged wild-type or S424Amutant HDAC3 in HEK293T cells. The transfected cells
were treated with insulin (0 or 50 nM, 2 hr). HA-HDAC3 protein was purified by HA beads and the co-
precipitated Flag-PGK1 was detected by western blot. The phrase ‘”9.5% input” refers to the fact that 9.5% of
total proteins for IP experiments were loaded. (F) Rapamycin treatment diminishes the effect of insulin on
changing HDAC3 S424 phosphorylation, HDAC3-PGK1 association, and PGK1 K220 acetylation. HEK293T
cells were treated with Rapamycin (5 nM, 2 hr) prior to insulin treatment (50 nM, 2 hr). Endogenous proteins
of PGK1 and HDAC3 were purified by IP with PGK1 and HDAC3 antibodies. Western blot was performed to
detect HDAC3-PGK1 interaction, and the indicated proteins and their phosphorylation. The phrase “9.5%
input” refers to the fact that 9.5% of total proteins for IP experiments were loaded. Supporting information can
be found in S10 Fig and S11 Fig.
doi:10.1371/journal.pbio.1002243.g006
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Fig 7. PGK1 K220 acetylation regulates glycolytic ATP production, glucosemetabolism, and redox
state of cells. (A) K220Qmutant PGK1 put-back cells display decreased glycolytic ATP production. Stable
HEK293T cells were treated without or with Rotenone (100 nM for 6 hr), following measurement of cellular
ATP production as described in S1 Text. The glycolytic ATP production in rescued cells expressing the empty
vector (VEC, white column), wild-type PGK1 (blue column), and K220Qmutant PGK1 (red column) was
compared. (B) K220Qmutant PGK1 put-back cells display decreased levels of 3-PG and serine. Stable
HEK293T cells were rinsed with 1 ml ice-cold PBS for less than 1 min and quenched by using 80% (v/v) pre-
cold (-80°C) methanol, following the standard LC-MSmethod to determine intracellular levels of 3-PG and
serine as described in S1 Text. (C) K220Qmutant PGK1 put-back cells exhibit impaired glycolytic function.
ECAR assay was performed in stable HEK293T cells using a Seahorse Bioscience XFe 96 analyzer system
as described in S1 Text. The glycolytic function of rescued cells expressing wild-type PGK1 (blue circle) and
K220Qmutant PGK1 (red circle) was compared. (D) K220Qmutant PGK1 put-back cells exhibit reduced
NADPH/NADP+ ratio. Stable HEK293T cells were treated without or with menadione (50 μM for 30 min), and
the ratio of NADPH/NADP+ was determined by enzymatic analysis as described in S1 Text. (E) K220Q
mutant PGK1 put-back cells exhibit higher ROS production. Stable HEK293T cells were treated without or
with menadione (50 μM for 30 min), and ROS accumulation was determined by using a fluorescent dye as
described in S1 Text. (F) K220Qmutant PGK1 put-back cells show higher susceptibility to ROS-induced cell
death. Stable HEK293T cells were treated with menadione at the indicated concentrations for 3 hr. The
viability of cells without or with PGK1 knockdown (white or black circle), and cells with PGK1 knockdown and
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glycolytic function, such as glycolysis, glycolytic capacity, and glycolytic reserve, were lower in
PGK1K220 mutant put-back cells than wild-type rescued cells (Figs 7C and S14). Glucose con-
sumption was significantly decreased (~60% less; p< 0.01), while glycogen storage was signifi-
cantly increased (by ~2.2-fold; p< 0.01) in the PGK1K220Q mutant put-back cells when
compared to wild-type rescued cells (S15A and S15B Fig). These results suggest that K220 acet-
ylation plays an important role in regulating PGK1 activity and/or function to modulate glyco-
lytic ATP production and glucose metabolism.
We also observed that stable knockdown of PGK1 led to a ~65% reduction in the NADPH/
NADP+ ratio in HEK293T cells (Fig 7D), suggesting that PGK1 is an important contributor to
NADPH pools besides its well-known role in glycolytic ATP production. Moreover, higher
ROS production was detected in PGK1 knockdown cells subjected to menadione, a quinone
compound that induces the production of superoxide radicals (Fig 7E). ROS has been exten-
sively implicated in signaling cascades, which function as important cell survival mechanisms
in response to oxidative stress [45]. We found that PGK1 knockdown cells exhibited higher lev-
els of cleaved PARP, an indicator of apoptosis (S16A Fig), as well as higher levels of p38 MAPK
phosphorylation, a stress-responsive kinase (S16B Fig). Importantly, re-expression of wild-
type PGK1, but not the acetylated mimetic K220Q mutant, restored the NADPH/NADP+ ratio
and suppressed ROS production in PGK1 knockdown cells subjected to menadione (Fig 7D
and 7E). Putting-back wild-type PGK1, but not the K220Q mutant, reduced the levels of
cleaved PARP and p38 MAPK phosphorylation in PGK1 knockdown cells when subjected to
menadione (S16A and S16B Fig). As a result, PGK1 knockdown cells exhibited a higher inci-
dence of cell death in response to menadione, and re-expression of wild-type PGK1, but not
the K220Q mutant, could rescue cells from menadione-induced cell death (Figs 7F and S17).
These results suggest that K220 acetylation plays an important role in regulating PGK1 activ-
ity/function to modulate NADPH redox and cellular oxidative response.
To further illustrate the role of K220 acetylation in controlling glucose metabolism and
redox potential in the cell, we generated PGK1 knockdown and put-back stable HEK293T cells,
in which endogenous PGK1 was depleted and the K220Q mutant was re-introduced at a higher
protein level in order to reach an equivalent PGK1 enzyme activity between the cells re-
expressing wild-type and K220Q mutant PGK1 (Fig 7G). By monitoring the reduction of
NADH, we found that the activity of wild-type PGK1 was significantly (p< 0.05) stimulated
by insulin treatment (Fig 7G), leading to a remarkable increase of 3-PG (by 3.2-fold; p< 0.01)
(Fig 7H). In contrast, cells with PGK1K220Q mutant put-back cells displayed a negligible change
in PGK1 enzyme activity and 3-PG upon insulin stimulation (Fig 7G and 7H). These findings
rescued by wild-type or K220Qmutant PGK1 (blue or red circle) was examined by counting the remaining
adherent cells using Trypan Blue. (G, H) K220Qmutant PGK1 put-back cells display a negligible response in
changing enzyme activity upon insulin treatment. Stable HEK293T cells were generated in which
endogenous PGK1was depleted and the acetylated mimic K220Qmutant was re-introduced at a higher
protein level in order to reach an equivalent PGK1 enzyme activity between the rescued cells expressing
wild-type and K220Qmutant PGK1. These stable cells were treated without or with insulin (50 nM for 2 hr),
following measurement of PGK1 activity (G) and relative 3-PG levels (H) as described in “Methods and
Materials” and S1 Text. (I) A working model depicting that the PI3K/AKT/mTOR pathway regulates HDAC3
Ser424 phosphorylation, which enhances the protein interaction between HDAC3 and PGK1 and decreases
PGK1 K220 acetylation, and that HDAC3-dependent regulation of PGK1 K220 acetylation modulates the
production of glycolytic ATP and 3-PG in the cell upon insulin stimulation. In A, B, D, E, F, G, and H, shown
are average values with standard deviation (S.D.) of triplicated independent experiments. In C, shown are
average values with standard error of the mean (S.E.M.) of triplicated experiments. * denotes p < 0.05 and **
denotes p < 0.01 for the indicated comparisons; # denotes p < 0.05 and # # denotes p < 0.01 versus untreated
group; n.s. = not significant. The numerical data and statistical analysis used in the figures are included in S1
Data. Supporting information can be found in S12, S13, S14, S15, S16, and S17 Figs.
doi:10.1371/journal.pbio.1002243.g007
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strongly support the notion that K220 acetylation plays an important role in regulating PGK1
activity/function in cells upon physiological stimulus, such as insulin.
Discussion
K220 Acetylation of PGK1 Regulates Substrate ADP Binding
The current study uncovers a biochemical mechanism for how acetylation controls the activ-
ity/function of PGK1. We have identified KAT9 and HDAC3 as the potential acetyltransferase
and major deacetylase of PGK1, respectively. To the best of our knowledge, we show for the
first time that acetylation of PGK1 plays an important role in modulating glycolytic energy
production and cellular oxidative response.
We have identified K220 as an important regulatory acetylation site within the PGK1 pro-
tein. Human PGK1 exists as a monomer containing two nearly equal-sized domains corre-
sponding to the N- and C-termini of the protein [30]. 1, 3-BPG binds to the N-terminal
domain whereas ADP binds to the C-terminal domain of PGK1 [46]. Though the binding of
either substrate 1,3-BPG or ADP triggers a conformational change, only through the binding
of both substrates does domain closure occur, bringing the two substrates into the proper vicin-
ity for phosphotransfer [47,48]. Of note, K220 locates in the C-terminus of PGK1 and interacts
with the nucleotide substrate ADP [48,49]. Our data show that acetylation mimetic K220Q
substitution significantly reduces PGK1 catalysis. This is best illustrated by the observation
that the recombinant PGK1K220ac protein is defective in ADP binding, implying that neutrali-
zation of the positive charge of K220 by acetylation may disrupt ADP binding and thus inhibit
PGK1 catalysis. It has to be noted that both acetylation mimetic K220Q substitution and deace-
tylation mimetic K220R substitution can significantly reduce PGK1 activity. This raises
another possibility, that is, the steric hindrance that occurs when K220 is mutated to Q or R,
and this will generate different interaction force and/or steric hindrance, thereby abolishing
ADP binding and inhibiting PGK1 catalysis.
Crosstalk between HDAC3 Phosphorylation and PGK1 Acetylation
Links Extracellular Physiologic Stimuli to Intracellular Metabolic Flux
Our study has provided novel insights into the role of K220 acetylation in controlling PGK1
activity/function in response to insulin. To the best of our knowledge, this is the first evidence
linking the regulation of PGK1 to mTOR downstream of PI3K/AKT and insulin. In addition,
we show a molecular crosstalk between mTOR-mediated HDAC3 S424 phosphorylation and
PGK1 K220 acetylation.
We have identified HDAC3 as the major deacetylase of PGK1. HDAC3 can form multi-pro-
tein complexes with the co-repressors SMRT and N-CoR and deacetylates histones, thereby
regulating the transcription of a plethora of genes [50,51]. In addition, many non-histone sub-
strates of HDAC3 have been identified, including the NF-ƘB protein RelA [52], sex-determin-
ing region Y (SRY, a master regulator of testis organogenesis) [53], and several transcription
factors such as p53 [54], myocyte enhancer factor-2 (Mef2) [55], and glial cell missing (GCMa)
[56]. Very recently, it was reported that HDAC3 deacetylates methionine adenosyltransferase
IIα (MAT IIα) in the methionine cycle [57], indicating that HDAC3 can deacetylate a meta-
bolic enzyme and may play an important role in regulating metabolic pathway(s). Supporting
this notion, we show in this study that another metabolic enzyme, PGK1, is a direct substrate
of HDAC3 and that HDAC3-mediated PGK1 deacetylation plays a signaling role in regulating
PGK1 activity/function upon insulin stimulation. Moreover, we demonstrate that the PI3K/
AKT/mTOR pathway regulates PGK1 K220 acetylation, in part, via affecting HDAC3 Ser424
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phosphorylation, suggesting a potential mechanism for HDAC3 Ser424 phosphorylation regu-
lating PGK1 K220 acetylation. Upon insulin stimulation, the PI3K/AKT/mTOR pathway
induces HDAC3 Ser424 phosphorylation, which increases the deacetylase activity of HDAC3
and/or enhances the protein association between HDAC3 and PGK1, leading to PGK1 K220
deacetylation and enzyme activation (Fig 7I). mTOR is a central cell growth controller and is
potently activated by insulin [58]. In addition, mTOR is also regulated by nutrient availability
and cellular energy status to control cellular metabolism. Our data provides a direct link of
mTOR activation to glycolysis, which is achieved by mTOR-mediated HDAC3 phosphoryla-
tion and PGK1 deacetylation, thus leading to PGK1 activation. These results also provide an
example illustrating how cells integrate different pathways such as extracellular growth signal-
ing and intracellular metabolic flux by a crosstalk involving different type of protein modifica-
tions such as phosphorylation and acetylation.
In addition, we have also identified KAT9 as a potential acetyltransferase of PGK1. KAT9/
ELP3, which encodes the catalytic subunit of the histone acetyltransferase elongator complex,
has previously been identified as an α-tubulin acetyltransferase in mouse neurons [59]. Previ-
ously, we reported that KAT9 is the potential acetyltransferase of glucose-6-phosphate dehy-
drogenase (G6PD), which is a key enzyme in the pentose phosphate pathway and plays an
essential role in the oxidative stress response by producing NADPH [60]. In this study, we
show that KAT9 as the potential acetyltransferase of PGK1 interacts with and increases PGK1
acetylation, thereby inhibiting PGK1 activity. However, KAT9 may not contribute to cells sens-
ing insulin signal to regulate PGK1 acetylation and function, as neither KAT9 expression nor
KAT9-PGK1 interaction is changed upon insulin treatment.
Acetylation of PGK1 Coordinates Energy Metabolism and Oxidative
Stress Response
Our study also links the regulation of PGK1 activity by acetylation to cellular response to oxi-
dative stress. We show that replacement of endogenous of PGK1 with an acetylation-mimetic
K220Q mutant results in a significant decrease in NADPH production and higher suscepti-
bility of cells to oxidative stress. The underlying mechanism for PGK1 controlling NADPH
production remains unclear. We propose that a general inhibition of glycolysis may at least
in part explain the reduction in NADPH production. In addition, we also show that both
3-PG and serine levels are significantly reduced in cells with PGK1 knockdown and put-back
of the acetylation mimetic K220Q mutant as compared to wild-type rescued cells (Fig 7B).
3-PG is essential for de novo serine biosynthesis [44]. Serine can be converted to glycine by
serine hydroxymethyl transferase, a reaction that yields one carbon units, which enter the tet-
rahydrofolate cycle and are critical for NADPH production [61,62]. Whether PGK1 K220
acetylation inhibits PGK1 catalytic activity, leading to reduced production of 3-PG, disturbed
serine biosynthetic flux, and subsequently reduced NADPH production, still needs further
investigation.
Recent work has suggested a critical role of serine metabolism in cancer pathogenesis [63–
65]. Supporting this notion, PHGDH gene expression is up-regulated in diverse cancer cells,
such as esophageal adenocarcinoma, triple-negative breast cancer, and melanoma [66]. More-
over, cancer cells with PHGDH amplification were found to exhibit increased metabolic flux
into serine biosynthesis, which is known to play a dual role in redox balance and providing
nucleotide units to support cancer cell proliferation [5,67]. As noted above, K220 acetylation
inhibits PGK1 activity/function and reduces the 3-PG and serine levels, implying that modula-
tion of PGK1 activity/function by acetylation may serve as a promising anti-cancer strategy
through regulating serine metabolism.
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Moreover, the clinical implication of PGK1 dysfunction has been highlighted by chronic
haemolysis with progressive neurological impairment in PGK1-deficient patients [68–70]. Two
metabolic alterations, a decreased steady-state level of ATP and an increased 2,3-BPG, in red
blood cells with human PGK1 deficiency have been proposed to cause hemolytic anemia [71].
It is known that hemolytic anemia also contributes to the inability of erythrocyte cells to pro-
duce NADPH and withstand harmful oxidants [72]. Likely, PGK1 dysfunction-associated
chronic haemolysis and neurological impairment are in part caused by oxidative stress due to
increased levels of oxidative damage and decrease levels of antioxidants, such as reductant
NADPH. In this study, we have provided evidence showing that HDAC3-dependent acetyla-
tion regulates the function of PGK1 in both glycolytic ATP production and NADPH redox.
Therefore, future therapeutic intervention(s) to modulate PGK1 activity via HDAC3-mediated
deacetylation may serve as a potential target for treating related diseases, such as hemolytic
anemia and brain disorders associated with PGK1 dysregulation.
Methods and Materials
Animal Research
All the animal experiments were carried out in accordance with the National Institutes of
Health guidelines for the Care and Use of Laboratory Animals and the regulations of Fudan
University for animal experimentation. MaleBALB/c mice (6–8 wk old, 20–25 g body weight)
were purchased from the Fudan Animal Center. Animals were given unrestricted access to a
standard diet and tap water. Blood was collected from tail vein at different time points post
intraperitoneal injection of insulin (5 U/kg body weight), and blood glucose levels were deter-
mined by using a glucose detection kit (Roche). Before being humanely killed, mice were anes-
thetized with sodium pentobarbital (25 mg pentobarbital/kg body weight, ip). After that,
mouse livers and kidneys were harvested and then homogenized using the Tissuelyser-24
(Shanghai JingXin) in 0.5% NP-40 buffer containing protease inhibitor cocktail, and lysed on
ice for 30 min. To determine the acetylation level of endogenous Pgk1, tissue lysates were incu-
bated with the Pgk1 antibody (Santa Cruz) for 1 hr, followed by incubating with Protein-A
beads (Upstate) for another 2 hr at 4°C.
Antibodies
The Rabbit anti-pan-acetyllysine antibody was generated as previously described [73]. To gen-
erate acetyl-lysine 220 specific antibody of PGK1, synthetic peptide VADKIQLINNMLDK was
coupled to KLH as antigen to immunize rabbit (Shanghai Genomic Inc). For more detail infor-
mation about the other antibodies used in this study, please refer to the S1 Text.
PGK1 Enzyme Activity Assay
Flag-tagged PGK1 protein was overexpressed in HEK293T cells, immumoprecipitated and
eluted by 250 mg/ml Flag peptides (Gilson Biochemical) dissolved in PBS (pH 7.5). The PGK1
activity assay was carried out as previously described [74]. The reactions were started by adding
enzyme into the buffer containing 80 mM pH 7.6 triethanolamine, 8.0 mMMgCl2, 0.25 mM
NADH, 2.4 mM ATP, 12 mM 3-phosphoglycerate and 50 μg/ml glyceraldehyde-3-phosphate
dehydrogenase in a total volume of 0.3 ml, and assayed at 25°C. By monitoring the reduction
of NADH fluorescence (Ex350 nm, Em470 nm), the specific PGK1 activity was measured
using HITACHI F-4,600 fluorescence spectrophotometer.
HDAC3 Deacetylates PGK1
PLOS Biology | DOI:10.1371/journal.pbio.1002243 September 10, 2015 18 / 27
Expression of the K220 Site-Specific Acetylated PGK1 Protein
The K220 site-specific acetylated PGK1 was expressed in E. coli as previously described [32,33].
In short, the ORF of PGK1 was cloned into pTEV-8 vector with amber codon being incorpo-
rated at lysine 220 (AAG to TAG by site-directed mutagenesis). The E. coli strain BL21 (DE3)
was transformed with three plasmids, pAcKRS-3, pCDF PylT-1, and pTEV-8-PGK1. Cells
were grown overnight in LB containing spectinomycin (50 μg/ml), kanamycin (50 μg/ml), and
ampicillin (150 μg/ml) at 37°C till OD600 reached 0.6–0.8. The culture was added with 20 mM
NAM and 10 mMN-acetyllysine (Sigma-Aldrich). Protein expression was induced at 37°C by
addition of 0.5 mM of isopropyl-1-thio-D-galactopyranoside (IPTG) for 3 hr. Afterward, the
cells were harvested, the K220-acetylated PGK1 protein was purified and then stored at −80°C
till further analysis.
Isothermal Calorimetric Titration (ITC) Assay
ITC assay was performed by using a MicroCal VP-ITC type microcalorimeter (MicroCal Inc.).
Briefly, temperature equilibration was allowed for 1–2 hr till to 20°C prior to the experiment.
PGK1 protein and ADP (Sigma) were dialyzed against 40 mM Tris-HCl (pH 7.4), 50 mM KCl,
and 10 mMMgCl2. All solutions were thoroughly degassed before being used by centrifugation
at 13,000 rpm for 20 min. The experiment was conducted by consecutively injecting 50 μM
ADP solution into the calorimetric cell containing 50 μM purified PGK1. The titration
enthalpy data was corrected for the small heat changes in control titrations of ADP solution
into the dialysis buffer.
Generation of PGK1 Knockdown and Put-Back Stable Cell Lines
To generate stable PGK1 knockdown cell pools in HEK293T cells, shRNA targeting PGK1 was
constructed, and retrovirus was produced using a two-plasmid packaging system as previously
described [75]. The shRNA targeting sequence for PGK1 is 50-GCTTCTGGGAACAAGGT
TAAA-30. The pMKO.1-puro shRNA construct was co-transfected with vectors expressing the
gag and vsvg genes into HEK293T cells. Retroviral supernatant was harvested 36 hr after trans-
fection, and mixed with 8 μg/mL polybrene to increase the infection efficiency. HEK293T cells
were infected with the retrovirus and selected in 1 μg/ml puromycin for 1 wk.
To generate PGK1 knockdown and put-back stable cell pools in HEK293T cells, two silent
nucleotide substitutions were introduced into Flag-tagged human wild-type or K220 mutant
PGK1 in the sequence corresponding to the shRNA targeted region. Both shRNA resistant
PGK1 were cloned into the retroviral pQCXIH-hygro vector and co-transfected with vectors
expressing the gag and vsvg genes in HEK293T cells to produce retrovirus. Retroviral superna-
tant was harvested 36 hr after transfection, and mixed with 8 μg/mL polybrene to increase the
infection efficiency. HEK293T cells with PGK1 knockdown were infected with the retrovirus
and selected in 1 μg/ml puromycin and 2 μg/ml hygromycin for 4 wk.
Measurement of Intracellular NADPH/NADP+ Ratio
The intracellular NADPH/NADP+ was measured by enzymatic cycling methods as previously
described [76,77]. Briefly, cells were counted and seeded in 10 cm dishes at a density of
1.5 × 106. After 24 hr, cells were lysed in 400 μl of extraction buffer (20 mM NAM, 20 mM
NaHCO3, 100 mMNa2CO3) and centrifuged at 1,200 g for 15 min. 150 μl of the supernatant
was incubated in a heating block for 30 min at 60°C for NADPH extraction. And then, 20 μl of
the cell extract with 160 μl of NADP-cycling buffer (100 mM Tris-HCl, pH8.0; 0.5 mM thiazo-
lylblue; 2 mM phenazine ethosulfate; 5 mM EDTA) containing 1.3 U of G6PD was added to a
HDAC3 Deacetylates PGK1
PLOS Biology | DOI:10.1371/journal.pbio.1002243 September 10, 2015 19 / 27
96-well plate. After incubation for 1 min at 30°C in darkness, 20 μl of 10 mMG6P was added
to well, and measured the change of absorbance at 570 nm every 30 s for 10 min at 30°C by
using SpectraMax M5 Microplate Reader (Molecular Devices). Subtracting NADPH (heated
sample) from the total of NADP+ and NADPH (unheated sample) was the level of NADP+.
Statistical Analysis
Statistical analyses were performed with a two-tailed unpaired Student's t test. Almost all data
shown represent the results obtained from triplicated independent experiments with standard
deviation of the mean (mean ± S.D.). The values of p< 0.05 were considered statistically signif-
icant. The numerical data and statistical analysis used in all figures are included in S1 Data.
Supporting Information
S1 Data. Excel spreadsheet containing, in separate sheets, the underlying numerical data
and statistical analysis for Figs 1A, 1B, 1C, 1E, 1F, 2A, 2D, 3C, 3D, 3E, 3G, 4A, 4B, 4D, 7A,
7B, 7C, 7D, 7E, 7F, 7G, 7H, S3, S5, S6, S7A, S8, S9, S13, S14B, S14C, S15A and S15B.
(XLSX)
S1 Fig. PGK1 acetylation is increased by treatment with TSA, but not NAM. Flag-PGK1
was overexpressed in HEK293T cells followed by treatment with nicotinamide (NAM, 10 mM)
(A) and trichostatin (TSA, 5 μM) (B) as indicated. After purification by immunoprecipitation,
the acetylation level of ectopically expressed Flag-PGK1 was analyzed by western blot using a
pan-anti-acetyllysine antibody (α-Pan-Ac) and normalized against Flag.
(TIF)
S2 Fig. K220 of PGK1 is evolutionarily conserved from yeast to human. The sequence align-
ment of PGK1 from different species was compared, and the putative acetylated lysine residues
of PGK1 identified by MS study were colored in red.
(TIF)
S3 Fig. K220R mutant displays a negligible response in changing acetylation and enzyme
activity upon NAM+TSA treatment. Flag-tagged wild-type PGK1, K75R or K220R mutant
were each overexpressed in HEK293T cells, following treatments with or without NAM (10
mM for 4 hr) and TSA (5 μM for 12 hr). Acetylation levels and activity of PGK1 were deter-
mined by western blot and enzymatic activity assay, respectively. Relative PGK1 acetylation
levels were normalized against Flag. Note that the acetylation levels of wild-type, K75R, and
K220R PGK1 in cells treated without or with NAM + TSA (i.e. the α-Pan-Ac bands) were
determined on the same gel, while the α-Flag loading control samples were loaded to two sepa-
rate gels. Shown are average values with standard deviation (S.D.) of triplicated experiments.
 denotes p< 0.01 for the indicated comparison; n.s. = not significant. The numerical data
and statistical analysis used in the figures are included in S1 Data.
(TIF)
S4 Fig. Characterization of the specificity of the α-acetyl-PGK1 (K220) antibody. (A) Dif-
ferent amounts of acetyl-K220 peptide or unmodified peptide were spotted on nitrocellulose
membrane, and the antibody specificity was determined by dot-blot assay. (B) HEK293T cell
lysates were separately used for western blot with the α-PGK1 antibody (lane 1), α-acetyl-
PGK1 (K220) antibody (lane 2), the α-acetyl-PGK1 (K220) antibody incubated with acetylated
peptide (lane 3), or unmodified peptide (lane 4). The image is comprised from four separate
western blots. (C) Flag-tagged vector, wild-type, or K220Q/R mutant PGK1 was transfected
into HEK293T cells and the acetylation level of each purified protein was measured by western
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blot using the site-specific α-acetyl-PGK1 (K220) antibody or pre-immune serum.
(TIF)
S5 Fig. The knockdown efficiency of a siRNA library with three siRNAs targeting each of
the indicated 19 KAT genes. The siRNA oligonucleotide was transiently transfected into
HEK293T cells, and the mRNA expression of each KAT gene was determined by quantitative
real-time PCR at 48 hr post transfection. Shown are average values with standard deviation (S.
D.) of triplicated experiments. The numerical data and statistical analysis used in the figures
are included in S1 Data.
(TIF)
S6 Fig. A dynamic change of Pgk1 K220 acetylation in mouse kidney after insulin injection.
Insulin (5 U/kg body weight) was intraperitoneally injected into BALB/c wild-type mice (n = 3
per group). At the indicated time points post injection, mouse kidney samples were harvested,
and the K220 acetylation levels of endogenous Pgk1 were examined by western blot. The rela-
tive Pgk1 K220 acetylation levels were normalized against endogenous Pgk1 protein. The
numerical data and statistical analysis used in the figures are included in S1 Data.
(TIF)
S7 Fig. Neither KAT9mRNA expression nor KAT9-PGK1 association is changed after
insulin treatment. (A) HEK293T cells were treated with insulin at the indicated concentra-
tions for 2 hr, and KAT9mRNA expression was determined by quantitative real-time PCR.
The expression of KAT9 was normalized against β-actin. Shown are average values with stan-
dard deviation (S.D.) of triplicated experiments. n.s. = not significant. (B) Flag-tagged PGK1
and/or HA-tagged KAT9 were transiently overexpressed in HEK293T cells, and the cells were
then treated without or with insulin (50 nM, 2 hr). PGK1 protein was purified by IP with Flag
beads, following western blot to detect its K220 acetylation level and interaction with KAT9.
The numerical data and statistical analysis used in the figures are included in S1 Data.
(TIF)
S8 Fig.HDAC3mRNA expression is not changed after insulin treatment.HEK293T cells
were treated with insulin at the indicated concentrations for 2 hr, and HDAC3mRNA expres-
sion was determined by quantitative real-time PCR. The expression ofHDAC3 was normalized
against β-actin. Shown are average values with standard deviation (S.D.) of triplicated experi-
ments. n.s. = not significant. The numerical data and statistical analysis used in the figures are
included in S1 Data.
(TIF)
S9 Fig. HDAC3 S424A mutant exhibits reduced deacetylase activity and impaired protein
association with PGK1.HA-tagged proteins of wild-type and HDAC3 S424A mutant were
transiently overexpressed in HEK293T cells. Cell extracts were immunoprecipitated and
assayed for the histone deacetylase activity of HDAC3 as described in S1 Text. Moreover, the
level of HDAC3 Ser424 phosphorylation and the protein association between ectopically
expressed HDAC3 and endogenous PGK1 were determined by western blot. Shown are aver-
age values with standard deviation (S.D.) of triplicated experiments. The numerical data and
statistical analysis used in the figures are included in S1 Data.
(TIF)
S10 Fig. The PI3K/AKT pathway regulates PGK1 K220 acetylation. (A, B) Inhibition of
PI3K increases the K220 acetylation level of ectopically expressed PGK1 and impairs the pro-
tein interaction between ectopic proteins of PGK1 and HDAC3. Flag-tagged PGK1 and HA-
tagged HDAC3 were transiently co-overexpressed in HEK293T cells, and then these
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transfected cells were treated with two PI3K inhibitors, LY294002 (A) or Wortmannin (B), at
the indicated concentrations for 4 hr and 2 hr, respectively. PGK1 proteins were purified by
Flag beads, following western blot to the detect K220 level acetylation of Flag-PGK1 and its
interacting HA-HDAC3.
(TIF)
S11 Fig. EGF cannot potently activate mTOR to change HDAC3 S424 phosphorylation and
PGK1 K220 acetylation. Flag-tagged PGK1 was ectopically expressed in HEK293T cells
treated with EGF (50 μg/L) for the indicated time periods. Endogenous proteins of ERK1/2,
S6K, HDAC3 and their phosphorylation were detected by western blotting. PGK1 proteins
were purified by Flag beads, and PGK1 K220 acetylation was determined by western blot.
(TIF)
S12 Fig. Generation of PGK1 knockdown and put-back stable cells. Stable HEK293T cells
with knockdown of endogenous PGK1 were transfected with retroviral plasmids expressing the
indicated proteins. PGK1 knockdown efficiency and re-expression were determined by western
blot.
(TIF)
S13 Fig. Determination of cell apoptosis in PGK1 knockdown and put-back stable cells sub-
jected to rotenone treatment. Stable HEK293T cells were treated with rotenone (100 nM) for
6 hr, and then the percentage of viable cells was determined by flow cytometric analysis using
Annexin V and propidium iodode (PI) antibodies as described in S1 Text. Shown are average
values with standard deviation (S.D.) of triplicated experiments. The numerical data and statis-
tical analysis used in the figures are included in S1 Data.
(TIF)
S14 Fig. Determination of the glycolytic function in PGK1 knockdown and put-back stable
cells. Extracellular acidification rate (ECAR) was determined in HEK293T cells with PGK1
knocking-down and putting-back using a Seahorse Bioscience XFe 96 analyzer system as
described in S1 Text (as shown in A). The glycolytic function of rescued cells expressing wild-
type PGK1 (blue circle), K220Q mutant PGK1 (red circle), and K220R mutant PGK1 (green
circle) was compared (B). The parameters reflecting glycolysis, glycolytic capacity, and glyco-
lytic reserve were determined by calculating Rate Measurement Equation (C). Shown are aver-
age values with standard error of the mean (S.E.M.) of triplicated experiments. The numerical
data and statistical analysis used in the figures are included in S1 Data.
(TIF)
S15 Fig. Determination of glucose consumption and glycogen content in PGK1 knockdown
and put-back stable cells. Relative glucose consumption (A) and glycogen storage levels (B) in
the indicated stable HEK293T cells were measured as described in S1 Text. Shown are average
values with standard deviation (S.D.) of triplicated experiments.  denotes p< 0.01 for the
indicated comparisons. The numerical data and statistical analysis used in the figures are
included in S1 Data.
(TIF)
S16 Fig. Determination of ROS-related signaling pathways in PGK1 knockdown and put-
back stable cells subjected to menadione treatment. (A, B) Stable HEK293T cells were treated
with menadione for the indicated concentrations and periods. The protein expression of PARP
and p38 MAPK and their phosphorylation were determined by western blot analysis.
(TIF)
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S17 Fig. Morphological changes of stable PGK1 knockdown and put-back cells subjected to
menadione treatment. Stable HEK293T cells were treated with menadione of the indicated
concentration for 3 hr. The changes in cell morphology were monitored under the microscope.
Scale bars are 200 μm.
(TIF)
S1 Table. The list of oligonucleotides and primer sequences used in this study.
(DOCX)
S1 Text. Supplementary materials and methods. For more details about antibodies, plasmids,
cell culture and treatment, immunoprecipitation and western blotting, RNA isolation and
quantitative real-time PCR, animal experiments, RNA interference, protein concentration
determination, protein expression and purification, pull-down assay, in vitro deacetylation
assay, HDAC3 activity assay, measurement of intracellular ATP levels, flow cytometry, liquid
chromatography mass spectrometry (LC-MS), extracellular acidification rate (ECAR), glucose
depletion assay, glycogen content measurement, measurement of intracellular ROS levels, or
cell survival assay, please refer to S1 Text.
(DOCX)
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